#LCSM Chat 5/26: Top 10 Key Abstracts on Lung Cancer (and Mesothelioma) at ASCO 2016: An #LCSM Preview

By Jack West, MD For the upcoming #LCSM chat on Thursday, 5/26 at 8 PM Eastern (5 PM Pacific) we’re going to do a preview of what are likely to be the most notable and clinically relevant presentations in lung cancer, and one in mesothelioma, at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago in early June. This meeting brings together over 30,000 cancer specialists every year to review thousands of presentations. Nobody can see it all, and one important aspect of not being overwhelmed is knowing what should… Read More

#LCSM Chat 5/5: Know Before You Go—Conference Prep 101

Lung cancer patients and advocates are increasingly joining healthcare, pharma, government agency and biotech industry representatives at cancer-related medical conferences such as the American Association for Cancer Research (AACR) Annual Meeting in April and the American Society for Clinical Oncology Annual Meeting in June. Planning ahead for these meetings is essential for getting the most out of your time. The events, which can last several days, often have many sessions happening at the same time in different rooms.  In addition to scheduling considerations, the terminology, graphics, and scientific concepts discussed in the… Read More

#LCSM Chat 4/21: Doctor Shopping in the Age of Social Media

The doctor-patient relationship is without a doubt a keystone of medical care.  This relationship is arguably most intense in the field of oncology.  For patients, few things are as life altering as a cancer diagnosis.  This is particularly true for lung cancer, given its poor survival statistics and the social stigma sometimes associated with the disease.  Thus, for many lung cancer patients, a surgeon or oncologist (sometimes both) become an incredibly important person for several months, if not years.  These doctors will gather the patients’ data, inform them of their diagnoses, administer… Read More